Alyeska Investment Group »

Aktis Oncology shares owned by Alyeska Investment Group

Quarter-by-quarter ownership of Aktis Oncology shares owned by Alyeska Investment Group from 13F filings

Historical chart of Alyeska Investment Group investment in Aktis Oncology

Tip: Access up to 7 years of quarterly data

All positions including Aktis Oncology held by Alyeska Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aktis Oncology by Alyeska Investment Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $5.2M 290k 17.89

More positions owned by Alyeska Investment Group

Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Micron Technology (MU)
Robinhood Mkts Com Cl A (HOOD)
Coreweave Com Cl A (CRWV)
Meta Platforms Cl A (META)
Uber Technologies (UBER)
Gpgi Com Cl A (GPGI)
Amphenol Corp Cl A (APH)
Cisco Systems (CSCO)
Hilton Worldwide Holdings (HLT)
Burlington Stores (BURL)
Merck & Co (MRK)
Zebra Technologies Corporati Cl A (ZBRA)

View all positions for Alyeska Investment Group

Top funds holding Aktis Oncology

MPM Oncology Impact Management
EcoR1 Capital
BlackRock
RA Capital Management
Henderson Group
Baker Bros. Advisors
Octagon Capital Advisors
Merck & Co
Vanguard Capital Management
Geode Capital Management
Avidity Partners Management
AH Capital Management
UBS Group
Arrowpoint Asset Management
Alyeska Investment Group

View all funds holding Aktis Oncology